ProfileOfResearchers

TÃTULO: Safety, pharmacokinetics, and pharmacodynamics of oral venglustat in Parkinson disease patients with a GBA mutation from Japan and the rest of the world: Results from part 'I of the MOVES-PD study Full Text
AUTORES: Judith J Peterschmitt; Hidemoto Saiki; Taku Hatano; Thomas Gasser; Stuart Isaacson; Jaime Kulisevsky; Tanya Simuni; Yuji Takahashi; Anne Marie Wills; Leonor Correia Guedes; Per Svenningsson; Ryosuke Takahashi; Cheryl Waters; Masahisa Katsuno; Allena Ji Ji; Sebastiaan J M Gaemers; Pascal Minini; Blandine Nembo; Pablo Sardi; Stephane Saubadu; Jyoti Sharma; Tanya Fischer; ...Mais
PUBLICAÇÃO: 2020, FONTE: 16th Annual Research Meeting of the WORLDSymposium(TM) in MOLECULAR GENETICS AND METABOLISM, VOLUME: 129, NÚMERO: 2

INDEXADO EM:

WOS

TÃTULO: Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in the Japanese and the Rest of the World Parkinson's Disease Population With a GBA Mutation: Results from Part 1 of the MOVES-PD Study
AUTORES: Judith J Peterschmitt; Hidemoto Saiki; Taku Hatano; Thomas Gasser; Stuart Isaacson; Jaime Kulisevsky; Tanya Simuni; Yuji Takahashi; Anne Marie Wills; Leonor Correia Guedes; Per Svenningsson; Ryosuke Takahashi; Cheryl Waters; Masahisa Katsuno; Allena Ji Ji; Sebastiaan J M Gaemers; Pascal Minini; Blandine Nembo; Pablo Sardi; Stephane Saubadu; Jyoti Sharma; Tanya Fischer; ...Mais
PUBLICAÇÃO: 2020, FONTE: Annual Meeting of the American-Academy-of-Neurology in NEUROLOGY, VOLUME: 94, NÚMERO: 15

INDEXADO EM:

WOS

TÃTULO: Safety, tolerability and pharmacokinetics of oral venglustat in Parkinson disease patients with a GBA mutation Full Text
AUTORES: Judith J Peterschmitt; Thomas Gasser; Stuart Isaacson; Jaime Kulisevsky; Pablo Mir; Tanya Simuni; Anne Marie Wills; Leonor Correia Guedes; Per Svenningsson; Cheryl Waters; Allena J Ji; Jian Li; Pascal Minini; Blandine Nembo; Stephane Saubadu; Jyoti Sharma; Tanya Fischer;
PUBLICAÇÃO: 2019, FONTE: 15th Annual Research Meeting of the WORLDSymposium(TM) in MOLECULAR GENETICS AND METABOLISM, VOLUME: 126, NÚMERO: 2

INDEXADO EM:

WOS

TÃTULO: Addendum to Letter to the Editor: Safety, efficacy, and authorization of eliglustat as a first-line therapy in Gaucher disease type 1 Full Text
AUTORES: Pramod K Mistry; Manisha Balwani; Hagit N Baris; Hadhami Ben Turkia; Andrew A Burrow; Joel Charrow; Gerald F Cox; Sumita Danda; Marta Dragosky; Guillermo Drelichman; Amal El Beshlawy; Cristina Fraga; Selena Freisens; Sebastiaan Gaemers; Evgueniy Hadjiev; Priya S Kishnani; Elena Lukina; Pierre Maison Blanche; Ana Maria Martins; Gregory Pastores; Milan Petakov; Judith J Peterschmitt; Hanna Rosenbaum; Barry Rosenbloom; Lisa H Underhill; Timothy M Cox; ...Mais
PUBLICAÇÃO: 2019, FONTE: BLOOD CELLS MOLECULES AND DISEASES, VOLUME: 77

INDEXADO EM:

Scopus

WOS

TÃTULO: Once- versus twice-daily dosing of eliglustat in adults with Gaucher disease type 1: The Phase 3, randomized, double-blind EDGE trial Full Text
AUTORES: Joel Charrow; Cristina Fraga; Xuefan F Gu; Hiroyuki Ida; Nicola Longo; Elena Lukina; Alexandre Nonino; Sebastiaan J M Gaemers; Marie Helene Jouvin; Jing Li; Yaoshi S Wu; Yong Xue; Judith J Peterschmitt;
PUBLICAÇÃO: 2018, FONTE: MOLECULAR GENETICS AND METABOLISM, VOLUME: 123, NÚMERO: 3

INDEXADO EM:

WOS

Links Úteis